These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26940099)

  • 21. Marein ameliorates diabetic nephropathy by inhibiting renal sodium glucose transporter 2 and activating the AMPK signaling pathway in db/db mice and high glucose-treated HK-2 cells.
    Guo Y; Ran Z; Zhang Y; Song Z; Wang L; Yao L; Zhang M; Xin J; Mao X
    Biomed Pharmacother; 2020 Nov; 131():110684. PubMed ID: 33152903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex differences in progression of diabetic nephropathy in OVE26 type 1 diabetic mice.
    Wang W; Jiang S; Tang X; Cai L; Epstein PN; Cheng Y; Sun W; Xu Z; Tan Y
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165589. PubMed ID: 31678163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
    Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
    Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1.
    Peng H; Luo P; Li Y; Wang C; Liu X; Ye Z; Li C; Lou T
    PLoS One; 2013; 8(11):e80009. PubMed ID: 24244596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence and expansion of hypoxia detected by pimonidazole adduct immunostaining during progression of diabetic nephropathy in diabetic mice.
    Inada A; Fukatsu A
    Am J Physiol Renal Physiol; 2023 Nov; 325(5):F527-F535. PubMed ID: 37615048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplantation of human fetal pancreatic progenitor cells ameliorates renal injury in streptozotocin-induced diabetic nephropathy.
    Jiang Y; Zhang W; Xu S; Lin H; Sui W; Liu H; Peng L; Fang Q; Chen L; Lou J
    J Transl Med; 2017 Jun; 15(1):147. PubMed ID: 28655312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.
    Barutta F; Bellini S; Kimura S; Hase K; Corbetta B; Corbelli A; Fiordaliso F; Bruno S; Biancone L; Barreca A; Papotti MG; Hirsh E; Martini M; Gambino R; Durazzo M; Ohno H; Gruden G
    Autophagy; 2023 Feb; 19(2):505-524. PubMed ID: 35659195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NAG-1/GDF15 inhibits diabetic nephropathy via inhibiting AGE/RAGE-mediated inflammation signaling pathways in C57BL/6 mice and HK-2 cells.
    Chen J; Peng H; Chen C; Wang Y; Sang T; Cai Z; Zhao Q; Chen S; Lin X; Eling T; Wang X
    Life Sci; 2022 Dec; 311(Pt A):121142. PubMed ID: 36367498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early-onset diabetic E1-DN mice develop albuminuria and glomerular injury typical of diabetic nephropathy.
    Hyvönen ME; Dumont V; Tienari J; Lehtonen E; Ustinov J; Havana M; Jalanko H; Otonkoski T; Miettinen PJ; Lehtonen S
    Biomed Res Int; 2015; 2015():102969. PubMed ID: 26000279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
    Zhong F; Chen H; Xie Y; Azeloglu EU; Wei C; Zhang W; Li Z; Chuang PY; Jim B; Li H; Elmastour F; Riyad JM; Weber T; Chen H; Wang Y; Zhang A; Jia W; Lee K; He JC
    J Am Soc Nephrol; 2018 May; 29(5):1397-1410. PubMed ID: 29511111
    [No Abstract]   [Full Text] [Related]  

  • 32. Apolipoprotein C3 aggravates diabetic nephropathy in type 1 diabetes by activating the renal TLR2/NF-κB pathway.
    Wang H; Huang X; Xu P; Liu X; Zhou Z; Wang F; Li J; Wang Y; Xian X; Liu G; Huang W
    Metabolism; 2021 Jun; 119():154740. PubMed ID: 33639183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 6-Shogaol ameliorates diabetic nephropathy through anti-inflammatory, hyperlipidemic, anti-oxidative activity in db/db mice.
    Xu Y; Bai L; Chen X; Li Y; Qin Y; Meng X; Zhang Q
    Biomed Pharmacother; 2018 Jan; 97():633-641. PubMed ID: 29101807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling.
    Dixon A; Maric C
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1678-90. PubMed ID: 17686959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.
    Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ
    Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sirt7 associates with ELK1 to participate in hyperglycemia memory and diabetic nephropathy via modulation of DAPK3 expression and endothelial inflammation.
    Li X; Liu J; Lu L; Huang T; Hou W; Wang F; Yu L; Wu F; Qi J; Chen X; Meng Z; Zhu M
    Transl Res; 2022 Sep; 247():99-116. PubMed ID: 35470010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotine exacerbates diabetic nephropathy through upregulation of Grem1 expression.
    Chen J; Xiao H; Xue R; Kumar V; Aslam R; Mehdi SF; Luo H; Malhotra A; Lan X; Singhal P
    Mol Med; 2023 Jul; 29(1):92. PubMed ID: 37415117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
    Wysocki J; Ye M; Khattab AM; Fogo A; Martin A; David NV; Kanwar Y; Osborn M; Batlle D
    Kidney Int; 2017 Jun; 91(6):1336-1346. PubMed ID: 27927599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amelioration of diabetic nephropathy using pomegranate peel extract-stabilized gold nanoparticles: assessment of NF-κB and Nrf2 signaling system.
    Manna K; Mishra S; Saha M; Mahapatra S; Saha C; Yenge G; Gaikwad N; Pal R; Oulkar D; Banerjee K; Das Saha K
    Int J Nanomedicine; 2019; 14():1753-1777. PubMed ID: 30880978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
    Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
    Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.